- Error
UNAIDS: More than 7 Million Africans on HIV Treatment, Deaths Continue to Fall
The number of people in Africa receiving antiretroviral medications increased from less than 1 million in 2005 to an estimated 7.1 million in 2012, according to a new report from UNAIDS. The report also notes that AIDS-related deaths and new HIV infections have both fallen by about 30% over the past decade.
![CROI 2013: Functional Cure of HIV-infected Infant after Early ART [VIDEO]](/images/resized/images/conf-photos/CROI2013/persaud-interview-img_3293-rect-500_330_228.jpg)
HIV/AIDS
Sangamo Reports Zinc Finger Gene Therapy Leads to Long-term CD4 Cell Gains, Shrinking HIV Reservoirs
An experimental gene therapy technique that modifies CD4 T-cells to protect them...
Reformulated Tenofovir Gel Found Safe and Acceptable for Anal Sex
Men and women found a microbicide gel containing 1% tenofovir -- which has...
U.S. Preventive Services Task Force Recommends Routine HIV Screening for Adolescents and Adults
On April 30 the U.S. Preventive Services Task Force (USPSTF) issued a "Grad...
Lack of Food Linked to More Hospitalizations among HIV+ People with Unstable Housing
Homeless and marginally housed people with HIV in San Francisco who experienced ...
Hepatitis B
EASL 2013: Do Asian Patients Respond Better to Pegylated Interferon for Hepatitis B?
Some Asian people with chronic hepatitis B treated with pegylated interferon may...
FDA Rejects Heplisav Hepatitis B Vaccine Seeking More Safety Data
The U.S. Food and Drug Administration (FDA) has declined to approve Dynavax...
National Hepatitis Testing Day: Most Infected Are Unaware, All Boomers Should Get HCV Test
In advance of the National Hepatitis Testing Day on Saturday, May 19, the U.S. C...
Everolimus (Zortress) Approved to Prevent Liver Transplant Rejection
The U.S. Food and Drug Administration (FDA) this month approved the immunos...
Hepatitis C
EASL 2013: Anemia Is a Common Side Effect of First-generation HCV Protease Inhibitors
About half of patients taking boceprevir (Victrelis) or telaprevir (Incivek or I...
Tattoos Are Associated with Hepatitis C Virus Infection in the Absence of Other Risk Factors
Individuals with chronic hepatitis C virus (HCV) infection in New York City were...
Sunday is Hepatitis Testing Day -- All Baby Boomers Should Get Hep C Test
May 19 is the second annual Viral Hepatitis Testing Day, an opportunity to raise...
Liver Cancer Increasing among People with HIV/HCV Coinfection
Hepatocellular carcinoma (HCC) is a growing problem among HIV positive people co...
HIV/Hepatitis Coinfection
Tenofovir plus Emtricitabine or Lamivudine Does Not Always Suppress Hepatitis B in HIV/HBV Coinfected
HIV/HBV coinfected people with high hepatitis B virus (HBV) levels and those who...
AASLD 2012: Final Study Results Show Telaprevir Is Safe and Effective for HIV/HCV Coinfected Patients
HIV/HCV coinfected people treated with telaprevir (Incivek) triple therapy are s...
Adefovir plus Hepatitis C Therapy May Prevent HBV Reactivation in HBV-HCV Coinfected Patients
Due to the similar transmission routes, many people are dually infected with bot...
Other Health News
World TB Day: U.S. Cases Hit New Low, Integration with HIV Care Needed Worldwide
The number of new tuberculosis (TB) cases in the U.S. fell below 10,000 in 2012 ...
Does Human Papillomavirus Contribute to Lung Cancer?
A small proportion of lung cancers may be caused by the same high-risk strains o...
Drug-resistant Gonorrhea Makes its Way into North America
The first documented failure of oral treatment for gonorrhea in North America ha...
2012-2013 Could Be Bad Flu Season, Not Too Late to Get Vaccine, CDC Advises
Significant increases in influenza activity in the U.S. during the past 2 weeks ...
Subscribe To Our Newsletter
Sign up for our free twice-weekly e-newsletter
CONTINUING MEDICAL EDUCATION
CONFERENCE COVERAGE
48th International Liver Congress (EASL 2013)
April 24-28, 2013, Amsterdam
|
Digestive Disease Week |
|
|
20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) |
|
 |
The Liver Meeting (AASLD 2012) |
 |
11th International Congress on Drug Therapy in HIV Infection (HIV11) |
 |
52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) |
 |
XIX International AIDS Conference (AIDS 2012) |
Copyright © 2013 hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com.
Joomla! is Free Software released under the GNU General Public License.
Web Design and Development by Bread and Roses Web Design